Synthetic data governance is the practical route through AI privacy bottlenecks

AI Trust & Governance

28 April 2026 | By Ashley Marshall

Most AI privacy debates get stuck on whether sensitive data can be used at all. The better question is how to create governed synthetic data products that let teams build, test and validate without casually moving real personal data around the business.

The privacy bottleneck is now an AI delivery bottleneck

AI programmes often slow down at the same point: teams need representative data, but the useful data contains customers, patients, employees, transactions, claims, tickets or operational patterns that privacy teams quite rightly treat as high risk. The result is a familiar queue. Data scientists wait for access approvals. Engineers build against toy data that behaves nothing like production. Compliance teams are asked to sign off experiments before the organisation has a clear view of purpose, controls, retention or downstream use.

Synthetic data governance is becoming a serious answer because it reframes the problem. Instead of treating sensitive source data as the default development fuel, the organisation creates synthetic data products that mimic the statistical patterns, structure and edge cases needed for testing and modelling. Those products are then governed like any other controlled asset: generated for a defined purpose, risk assessed, labelled, versioned, monitored and retired when no longer needed.

This matters in the UK because the regulatory signal is not simply "avoid data". The ICO guidance on AI and data protection stresses security, data minimisation and careful assessment of privacy attacks in AI systems. The government Data and AI Ethics Framework also points teams towards anonymised or synthetic data for testing where possible. In other words, the direction of travel is practical: use less real personal data where you can, but keep the governance evidence strong.

What this means in practice is that synthetic data should not sit in a lab as a clever technical side project. It should sit inside the delivery lifecycle. Product owners should know when synthetic data is acceptable, legal teams should know when the source generation process still involves personal data, and engineering teams should know which synthetic dataset is approved for unit testing, integration testing, model evaluation or partner demonstrations. That is where synthetic data starts to unblock delivery rather than create another governance document nobody uses.

Synthetic data is not one thing, and governance has to reflect that

A common mistake is to discuss synthetic data as if every synthetic dataset has the same privacy profile. It does not. At one end, structural synthetic data may only preserve column names, data types and plausible values. It is useful for pipeline development, schema checks and training new analysts, but not for meaningful modelling. At the other end, high fidelity synthetic data may preserve correlations, conditional distributions and rare patterns closely enough to support model development and analysis. That is far more valuable, but it can also carry higher reidentification and attribute disclosure risks.

The health sector is already explicit about this nuance. The AI and Digital Regulations Service for health and social care describes synthetic data as data that replicates patterns and statistical properties of real data, and notes methods such as Generative Adversarial Networks, rule based generation and data masking. It also warns that when synthetic data is generated from confidential patient information or personal data, the act of creating it is still subject to data protection legislation and the common law duty of confidentiality. That distinction is crucial for any board that has been told synthetic data is automatically outside compliance scope.

The useful governance move is to tier synthetic data by purpose and risk. Low fidelity data can usually be approved for broad internal testing. Medium fidelity data might be suitable for analytics prototyping or vendor evaluation under controlled access. High fidelity data used for model training, fairness testing or clinical style analytics should require stronger evidence: generation method, source lineage, privacy risk assessment, utility testing, permitted uses, retention period and a named owner.

Tools can help, but they do not replace the governance model. Vendors such as Mostly AI, Gretel, Tonic.ai, Hazy and Syntho can generate tabular synthetic data and support privacy and utility reporting. In healthcare and research contexts, teams may use GANs, variational autoencoders or differentially private approaches. The buying question should not be "can this tool make realistic data?" It should be "can we prove what was generated, why it was safe enough for the intended use, and when the risk needs to be reassessed?"

The UK compliance point: generation is still processing

The most dangerous misconception is that synthetic data is a regulatory escape hatch. It can reduce privacy risk, and some synthetic data may fall outside personal data rules once properly anonymised, but the path to that point still matters. If the source data used to train or create the synthetic dataset contains personal data, then the generation process itself is processing. That means the organisation still needs a lawful basis, purpose clarity, minimisation, security controls, retention rules and documentation.

The ICO anonymisation guidance is helpful here because it pushes organisations to think in terms of identifiability risk rather than labels. Anonymous information is not personal data, but calling a dataset anonymous does not make it so. The relevant question is whether individuals are identifiable by someone using means reasonably likely to be available. The ICO also discusses governance measures, accountability, staff training and the need to review identifiability risk assessments. That logic applies directly to high value synthetic data used in AI projects.

For UK businesses, the governance artefact should look more like a data product record than a one page legal note. It should say what source data was used, whether special category or confidential data was involved, what synthesis method was applied, what privacy tests were run, what utility tests passed, who can access the result, what use cases are forbidden and when the assessment expires. Where the data supports automated decision making or customer impacting AI, it should link to the DPIA, model risk assessment and procurement records.

What this means in practice is that synthetic data can make privacy governance faster only if the repeatable route is designed upfront. If every synthetic dataset triggers a fresh debate about definitions, risk appetite and approval ownership, the organisation has not solved the bottleneck. It has renamed it. A better operating model is to preapprove generation patterns for common use cases: software testing with structural data, analytics prototyping with medium fidelity data, and high fidelity model validation under restricted conditions.

Privacy attacks are the reason synthetic data needs real controls

The leading counterargument is fair: if synthetic data is generated from real data, could it leak information about real people? The answer is yes, if it is poorly generated or casually released. That does not make synthetic data useless. It means synthetic data needs the same maturity we expect from other privacy enhancing technologies. The risk is not theoretical. The ICO AI guidance describes privacy attacks including model inversion and membership inference. NHS England Digital says its Analytics Unit has explored adversarial attacks against SynthVAE to understand what information about original training data might be gained from a model alone.

In plain English, membership inference asks whether an attacker can determine that a particular individual was in the training dataset. Model inversion asks whether outputs can be used to reconstruct sensitive information about training records. Attribute disclosure asks whether an attacker can infer a sensitive characteristic from other patterns. Synthetic data that preserves rare combinations too faithfully can make these risks worse, especially in small populations, health contexts, fraud datasets or senior employee datasets where unique records stand out.

This is where governance has to become testable. Synthetic data should be evaluated for utility and privacy, not only realism. Utility tests might compare distributions, correlations, missingness, downstream model performance and business rule coverage. Privacy tests might include nearest neighbour analysis, linkage attack simulation, membership inference testing, k-anonymity style checks and differential privacy where appropriate. The AI and Digital Regulations Service specifically points to model inversion, membership inference and attribute disclosure risk as considerations when assessing synthetic health data.

The practical control is a release decision. Some synthetic data can be open internally. Some should only be available in a controlled workspace. Some should never leave a secure research environment. The policy should also forbid using synthetic data as a route to bypass contractual restrictions, patient expectations, employee privacy notices or sector duties. The strongest teams treat synthetic data as a governed derivative asset, not a disposable copy. That mindset keeps the privacy benefit while avoiding the false comfort that "fake" data is always safe data.

Synthetic data governance is also an AI quality control

Privacy is the obvious driver, but quality may be the bigger long term reason to govern synthetic data properly. AI systems are only as useful as the conditions they have been tested against. If a synthetic dataset smooths out rare events, removes awkward outliers or reproduces historical bias, a model can look safe in testing and fail when exposed to real customers. Conversely, a well governed synthetic dataset can deliberately include edge cases that production data does not expose often enough: vulnerable customer journeys, unusual claims, rare clinical combinations, failed payments, complaint escalations or multilingual support tickets.

This is why synthetic data governance should include a utility owner as well as a privacy owner. Privacy teams can judge reidentification and disclosure risk, but domain experts need to judge whether the data is fit for the decision being made. The UK government framework highlights fairness, transparency, accountability and safety as part of responsible data and AI work. Synthetic data governance should translate those principles into practical checks: does the dataset preserve the groups that matter, does it support bias testing, does it document known limitations, and can reviewers understand how it was generated?

Healthcare gives a useful named example. A 2025 npj Digital Medicine article on lessons from care.data notes that NHS data spans lifetimes and systems, and argues synthetic data could help improve model accuracy and fairness across subgroups if confidentiality, consent and transparency are handled properly. The same article records that the abandoned care.data programme had received 1.5 million opt-outs by 2016. That is a useful warning for every sector: technical privacy claims do not compensate for weak transparency and poor stakeholder confidence.

What this means in practice is that businesses should maintain a synthetic data catalogue with quality notes. Each dataset should show intended use, prohibited use, fidelity level, source period, population coverage, bias limitations, privacy controls and validation results. If a model was evaluated using synthetic data, that fact should appear in model documentation. If a dataset is refreshed, downstream tests should be repeatable. Governance is not bureaucracy here. It is how leaders avoid approving AI based on beautiful test results built on misleading data.

The operating model: treat synthetic data as a product, not a workaround

The organisations that get this right will not create a synthetic data committee for every AI experiment. They will create an operating model that lets teams move quickly inside pre-agreed guardrails. That starts with a simple policy taxonomy: structural synthetic data for engineering, medium fidelity synthetic data for analytics prototyping, high fidelity synthetic data for model development and tightly controlled synthetic data for regulated or sensitive use cases. Each tier should have different approval, testing and access requirements.

Second, assign ownership. A data protection officer or privacy lead should not be the only person accountable. Synthetic data needs a product owner, a technical owner, a privacy owner and a domain approver for high impact uses. Security also has a seat at the table. The NCSC secure AI system development guidance urges AI providers to consider secure design, secure development, secure deployment and secure operation across the lifecycle. Synthetic data generation pipelines are part of that lifecycle and should be logged, access controlled and monitored like other AI assets.

Third, make the evidence reusable. Create templates for synthetic data generation records, privacy testing, utility testing and release decisions. Define minimum tests for common use cases. Keep generation code, prompts, configuration and model versions under change control where possible. If a vendor is involved, require documentation on training behaviour, privacy metrics, support for differential privacy, audit logs, data residency and deletion. Procurement should ask those questions before teams become dependent on a tool.

Finally, link synthetic data to business value. The point is not to produce impressive fake records. The point is to unblock safe AI delivery: faster testing, safer vendor demos, better fairness evaluation, more realistic sandboxes, less unnecessary exposure of real customer data and clearer evidence for regulators or boards. That is why governance matters. Without it, synthetic data becomes another shadow dataset. With it, it becomes the practical route through the privacy bottlenecks that are currently slowing AI adoption.

Frequently Asked Questions

Is synthetic data always outside UK GDPR?

No. Some synthetic data may be anonymous enough to fall outside UK GDPR, but creating it from personal data is still processing. Organisations need to assess identifiability risk and document the generation process.

What is the main privacy risk with synthetic data?

The main risk is residual disclosure, especially through membership inference, model inversion, linkage or attribute inference attacks. High fidelity datasets usually need stronger testing and access controls.

Can synthetic data be used for model training?

Yes, but it depends on fidelity, quality and intended use. It can be useful for training or augmentation, but teams must test whether it preserves relevant patterns without amplifying bias or leaking source data.

How should a business start with synthetic data governance?

Start with low risk engineering and testing use cases, define data tiers, assign owners, create generation records and agree minimum privacy and utility tests before expanding into model development.

Which UK guidance is most relevant?

Relevant sources include ICO AI and data protection guidance, ICO anonymisation guidance, the UK Data and AI Ethics Framework and NCSC secure AI system development guidance. Sector specific health projects should also consider NHS and HRA expectations.

Does synthetic data remove the need for a DPIA?

Not necessarily. If the project involves high risk processing, sensitive source data, automated decision making or significant effects on individuals, a DPIA may still be needed. Synthetic data can be one risk reduction measure within it.

What should be in a synthetic data record?

Include source data, purpose, generation method, fidelity level, privacy tests, utility tests, permitted uses, prohibited uses, access controls, owner, retention period and reassessment date.

What is the biggest misconception about synthetic data?

The biggest misconception is that synthetic means safe by default. Synthetic data is safer only when it is generated, tested, governed and released according to the risk of the use case.